Guardant Health to Report Second Quarter Financial Results on August 5, 2021

Rhea-AI Summary

Guardant Health, Inc. (Nasdaq: GH) will report its financial results for Q2 2021 on August 5, 2021, after the market closes. A conference call will be held at 1:30 p.m. PT / 4:30 p.m. ET, which will be available for live listening on the company’s website. Guardant Health focuses on precision oncology with proprietary tests like Guardant360® and Guardant Reveal™, aiming to improve patient outcomes and reduce healthcare costs across cancer care stages.

Positive

• Guardant Health continues to innovate with multiple commercially launched tests for cancer patients.
• The company is positioning itself strongly within the oncology market by leveraging advanced analytics.

Negative

• None.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2021 after market close on Thursday, August 5, 2021. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the “Investors” section of the company website at: www.guardanthealth.com. The webcast will be archived and available for replay after the event.

About Guardant Health

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched Guardant360^®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantOMNI^® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210713005243/en/

FAQ

When will Guardant Health report its Q2 2021 financial results?

Guardant Health will report its Q2 2021 financial results on August 5, 2021, after market close.

What time is the Guardant Health conference call for Q2 2021?

The conference call will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Where can I listen to the Guardant Health Q2 earnings call?

The earnings call can be listened to live on the 'Investors' section of Guardant Health's website.

What is the focus of Guardant Health?

Guardant Health is a precision oncology company focused on improving cancer care through innovative testing and analytics.